News

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Novavax (NVAX) closed the most recent trading day at $6.61, moving -2.79% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.79% for the day. At the ...
The stock's fall snapped a three-day winning streak.
The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.